Close Menu

For a Good Cause

23andme is expanding its 23andWe initiative, which aims to acquire detailed health and trait data from existing customers, by recruiting 10,000 Parkinson's disease patients for a targeted analysis of the genetic and environmental causes of this disease. The program, backed in part by the Michael J. Fox Foundation, was announced on the 23andMe blog. Parkinson's patients get access to the full features of a 23andMe genome scan for $25 in return for participation in online surveys.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Nature News reports that researchers in Japan hope to soon test the use of reprogrammed stem cells to treat damaged corneas.

A new approach may help limit the number of fish that are mislabeled at markets or restaurants, according to New Scientist.

At Slate, the R Street Institute's Nila Bala discusses the privacy rights of suspects that genetic genealogy approaches in law enforcement bring up.

In PNAS this week: numerous mobile genetic elements contribute to Vibrio cholerae drug resistance, troponin I mutations in sudden infant deaths, and more.